Several of the many people who write or track RxISK posts, have had input to this one, which dovetails with Harriet Vogt's post last week Repairing Ruptures in Clinical Care and the work of Shane Cooke and Mary Hennessey in getting health systems to listen to the voices of those harmed by treatment. The post,| RxISK - Making Medicines Safer for All of Us
Better Times Will Return © Josie Russell 2017 This post is by our warzone correspondent Harriet Vogt from frontline trenches. A few weeks ago I was invited to join an online discussion with a group of experts on iatrogenesis who have an in-depth knowledge of antidepressant withdrawal and the risks of polypharmacy. These highly informed,| RxISK - Making Medicines Safer for All of Us
The Serotonin Reuptake Inhibitor (SRI) story starts in 1969 with Arvid Carlsson (above) who created Zelmid, the first SRI, after listening to people on antidepressants. He linked an anxiolytic effect some older drugs have to the serotonin system. The SRIs aimed at exploring that effect - Normality and Antidepressant Dysregulation. Fluoxetine (Prozac). sertraline (Zoloft). paroxetine| RxISK - Making Medicines Safer for All of Us